Current Projects: Health and Healthcare

  • Supporting the 'Britain's Healthiest Workplace' Competition

    Now in its fifth year, Vitality's annual Britain's Healthiest Workplace contest continues to receive research support from RAND Europe and the University of Cambridge. RAND Europe’s role includes designing and running surveys, analysing results, and providing customised reports to participating organisations. The project’s central aims are to raise awareness and gain a better understanding of how organisations can engage with the wellness of their employees.

  • Developing a Protocol for the Evaluation of ECDC Disease Programmes

    The European Centre for Disease Prevention and Control is planning a future evaluation of its seven ECDC Disease Programmes and has asked RAND Europe to establish a common protocol for the evaluation.

  • Exploring and Communicating the Value of Health Data

    To better understand the value of different types of health data, the European Federation of Pharmaceutical Industry Associations has asked RAND Europe to conduct a targeted rapid evidence review of current insights on the topic.

  • Evaluation of the Southern Cluster Urgent and Emergency Care Vanguards

    UEC vanguards were established to improve the coordination of NHS emergency services, direct urgent cases to the most appropriate provider, and reduce pressure on accident & emergency departments. RAND Europe is evaluating the UEC vanguards' new care models to determine their impact and possible scalability.

  • Supporting the Evaluation of Age UK's Integrated Care Programme

    Age UK is defining the plans for future evaluations of its Integrated Care Programme, which brings together voluntary organisations and health and care services to provide personalised support for older people. Research by RAND Europe will help to inform those evaluation plans.

  • The Contribution of UK Public Health Research to Clinical Guidelines

    The Department of Health commissioned RAND Europe to measure and characterise the contribution of UK public health research to UK clinical guidelines. The project team was also asked to carry out a comparison with other areas of healthcare and across different areas of public health such as smoking, alcohol abuse, skin cancers, physical activity and obesity

  • RAND Europe Focus on HIV/AIDS

    Policy responses and decision making around HIV/AIDS must be informed by rigorous analysis. With funding and support from a range of public and private organisations, RAND Europe has conducted a number of studies examining and evaluating HIV/AIDS research, prevention and treatment strategies.

  • Exploring Community-Based Social Innovations (CBSIs) for Healthy Ageing

    Researchers are examining how CBSIs are functioning across a number of rapidly ageing countries. Documenting the policies, programmes and health system factors underpinning their success will help to ensure greater sustainability and integration of services.

  • Focusing on Mental Health and Wellbeing

    RAND Europe’s growing work in the field of mental health and wellbeing draws on expertise from across a range of disciplines and methodological backgrounds to bring an innovative perspective to our projects. In particular, our well-established reputation in healthcare research is complemented by extensive science policy expertise, particularly in the field of research evaluation.

  • Understanding How Organisations Ensure Fair Decision Making

    The General Medical Council has asked RAND Europe to identify relevant lessons from multiple sectors in the UK where professionals make complex, high-impact decisions in a regulatory context. Researchers are investigating the tools, practices and processes used by organisations in the healthcare regulation, legal regulation and defence and security sectors.

  • Analysing the Impact of the Workplace Wellbeing Charter

    Public Health England has commissioned an analysis of the take-up and impact of the Workplace Wellbeing Charter; the end product will include a set of case studies to help strengthen and expand the evidence base that underpins the Charter.

  • Evaluating the Improving Flow Programme

    To help improve patient flow through the healthcare system, researchers are evaluating a novel programme that applies team coaching skills and improvement science at the care pathway level.

  • Pre-Evaluation of the Communities of Practice (CoPs) Programme

    A scoping exercise will help plan and prepare for a more systematic and complete evaluation of the Health Innovation Network's Communities of Practice, while also providing immediate evidence to help CoPs improve their effectiveness.

  • Exploring Funding Options for the NHS and Social Care in the UK

    To improve the quality of debate on the long-term funding of health and social care in the four countries of the UK, the Health Foundation has commissioned RAND Europe to carry out research on the public acceptability of different funding models.

  • Using Ambulance Data for Injury Surveillance

    West Midlands Police, with support from RAND Europe, the University of Cambridge and Addenbrooke’s Hospital, is evaluating the use of ambulance data to support injury surveillance and violence reduction.

  • Updating the 'Vitality Age' Calculator

    The Vitality Age Calculator is an online tool that gives users a ‘snapshot’ of their overall health based on lifestyle choices and clinical factors. RAND Europe is helping Vitality UK to update their underlying calculations.

  • Helping the NHS Evaluate and Promote the Health of its Workforce

    A comprehensive survey of staff health and wellbeing at a selection of NHS organisations will map in detail the physical and mental health of NHS staff as well as their perceptions of existing work-wellbeing initiatives and organisational culture.

  • Evaluating the Impact of EU R&D into PRNDs

    A research team from RAND Europe and several other organisations are evaluating the role of EU-funded R&D into poverty-related and neglected diseases, in particular examining contributions to achieving universal health coverage and improving population health in low and middle-income countries.

  • Innovation in the NHS: Strategies for Future Sustainability and Impact

    To provide specific and actionable lessons and to help improve the innovation process, its outcomes, and impacts on population health, researchers from RAND Europe and the University of Manchester are exploring the different ways innovation occurs in National Health Service organisations.

  • Providing Medical Support to Light Footprint Operations

    Researchers are working to identify options for providing effective medical support to Light Footprint Operations and will define the technology, resources and skill sets necessary to achieve an appropriate level of support.

  • Research to Aid the Fight Against Cancer

    As part of the global fight against cancer, RAND Europe has led and collaborated on a number of studies exploring the impact of cancer research, the quality of care for cancer patients and the future outlook of different forms of cancer. Our findings and recommendations help inform future research, treatments and ultimately, care for cancer patients.

  • How to Increase Transparency, Engagement in the EFSA Risk Assessment Process

    The European Food Safety Authority asked RAND Europe to assess proposed transparency measures to determine which are most likely to be effective and what the impacts of their implementation would be.

  • Evaluation of the Southwark and Lambeth Integrated Care Older People's Programme

    An ongoing programme evaluation seeks to assess changes in hospital utilisation by older people in Southwark and Lambeth, following implementation of case management interventions, and whether the additional investment made through the programme has cost more or less than the savings made.

  • Evaluating the Optimal Lengths of Prescription Plans

    A review of clinical and economic evidence, followed by economic modelling, will provide the National Institute for Health Research with a high-quality reference on the clinical and cost-effectiveness of 3 month vs 28 day prescriptions in patients with stable chronic diseases.

  • Calculating the Economic Returns of Musculoskeletal Research

    A team of researchers from RAND Europe, King’s College London and HERG is estimating the health and economic benefits of UK investment in medical research into musculoskeletal conditions.